{"id":829621,"date":"2026-07-27T17:35:10","date_gmt":"2026-07-27T17:35:10","guid":{"rendered":"https:\/\/www.newsbeep.com\/ca\/829621\/"},"modified":"2026-07-27T17:35:10","modified_gmt":"2026-07-27T17:35:10","slug":"deadline-fast-approaching-for-canadians-to-file-claim-in-class-action-drug-suit","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/ca\/829621\/","title":{"rendered":"Deadline fast approaching for Canadians to file claim in class-action drug suit"},"content":{"rendered":"<p>MONTREAL \u2014 The deadline is fast approaching for Canadians to claim their share of a multimillion-dollar class-action lawsuit over the drug Rexulti.<\/p>\n<p>Canadians have until Aug. 27 to file a claim for their share of a $4.75 million settlement over the antipsychotic medication used to treat schizophrenia and depression.<\/p>\n<p>Quebec Superior Court approved the settlement in November, one year after authorizing the national class action against Otsuka Canada Pharmaceutical Inc. and Lundbeck Canada Inc.<\/p>\n<p>The class action covers Canadians who were prescribed the drug since February 2017 and later developed compulsive behaviours or impulse-control disorders such as gambling, shopping or binge-eating.<\/p>\n<p>Lawyers representing affected patients and families have said the deal is a compromise with no admission of liability. <\/p>\n<p>Applicants could receive anywhere from roughly $6,500 for mild cases to more than $102,000 in more severe cases.<\/p>\n<p>This report by The Canadian Press was first published July 27, 2026.<\/p>\n<p>The Canadian Press<\/p>\n<p>\t\tKeep it Factual<\/p>\n<p>Add CityNews Vancouver as a trusted source on Google to see more local stories from us.<\/p>\n<p>\t\t<a href=\"https:\/\/www.google.com\/preferences\/source?q=vancouver.citynews.ca\" rel=\"nofollow noopener\" target=\"_blank\"><br \/>\n\t\t<img loading=\"lazy\" decoding=\"async\" class=\"add-trusted-source-badge\" src=\"https:\/\/www.newsbeep.com\/ca\/wp-content\/uploads\/2026\/05\/1778189171_473_google-trusted-badge.png\" alt=\"Add as a preferred source on Google\" width=\"198\" height=\"63\"\/><br \/>\n\t\t<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"MONTREAL \u2014 The deadline is fast approaching for Canadians to claim their share of a multimillion-dollar class-action lawsuit&hellip;\n","protected":false},"author":2,"featured_media":829622,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[33],"tags":[49,48,84,377,47],"class_list":["post-829621","post","type-post","status-publish","format-standard","has-post-thumbnail","category-medication","tag-ca","tag-canada","tag-health","tag-medication","tag-national"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts\/829621","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/comments?post=829621"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts\/829621\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/media\/829622"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/media?parent=829621"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/categories?post=829621"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/tags?post=829621"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}